Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0563
Host Cell : HEK293T Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0563 |
| Description | This cell line is derived from HEK293T and is engineered to stably overexpress Dog TNFRSF18. |
| Target Gene | TNFRSF18 |
| Gene Species | Canis lupus familiaris (Dog) |
| Host Cell | HEK293T |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: Try changing the culture medium or coating culture plates with cell adhesion promoters such as collagen or fibronectin to enhance cell adhesion.
A: Optimize the choice and dilution of antibodies, extend incubation time, and ensure cell viability during processing and analysis.
A: Optimize cell lysis conditions, use appropriate immunoprecipitation reagents and antibodies for TNFRSF18 protein, ensure sufficient incubation time, and proper washing steps.
A: Optimize the design of sgRNA, improve the expression efficiency of Cas9, ensure the accessibility of the target sequence, and use efficient transfection methods.
A: Optimize protein extraction process, ensure suitable electrophoresis and transfer conditions, and use high-affinity and specificity antibodies for detection.
A: Use standardized apoptosis detection methods, ensure consistency in experimental conditions, including the concentration and duration of treatment agents, and perform multiple repetitions to increase the reliability of data.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.